Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
DOAC’s bij sinustrombose veilig en patiëntvriendelijk
apr 2025 | Neuro-vasculair